# David Fitzgerald

> David Fitzgerald is a Series A investor at Petra Capital Partners backing Health Care. See 12 investments, round sizes, portfolio and contact details…

- Type: Angel Investor
- Fund: Petra Capital Partners
- Location: Nashville, United States
- Total investments: 12
- Last investment: Apr 2023
- Lead investor: 50%
- Last updated: Oct 2026
- LinkedIn: https://www.linkedin.com/in/david-fitzgerald-32655a43

David Fitzgerald is a Series A investor at Petra Capital Partners in Nashville focused on Health Care and Medical. David Fitzgerald is based out of Nashville, Tennessee and is the Managing Partner of Petra Capital Partners. David previously worked at Three Oaks Hospice as a Board Member. David Fitzgerald attended the Washington and Lee University.

## Contacts

5 contacts available for David Fitzgerald: work email, personal email, work phone, personal phone and socials. Sign up free to unlock them: https://app.shizune.co/sign-up/investor-profiles/find-email/david-fitzgerald?utm_source=investor_profile

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Health Care | 5 | 42% |
| Medical | 3 | 25% |
| Hospital | 3 | 25% |
| Biotechnology | 3 | 25% |
| Health Diagnostics | 2 | 17% |

17 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Series A | 3 | 25% |
| Funding Round | 3 | 25% |
| Seed | 1 | 8% |
| Series B | 1 | 8% |
| Series C | 1 | 8% |

7 stages tracked in total.

## Investments

| Company | Description | Round size | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| American Vascular Associates | American Vascular Associates' vision is to expand and support a synergistic model of outpatient solutions that is physician-driven and patient-focused. |  | Private Equity | Apr 26, 2023 | https://americanvascular.com |
| Urgent Team Holdings, Inc. | Urgent Team Holdings, Inc. operates urgent care centers that provide urgent and primary health care services. It offers services for patients in the areas of sprains, strains, and broken bones; muscular pain and injuries; eye irritation and eye injuries; cuts and scrapes; bites, stings, and allergic reactions; burns and infections; diarrhea,nausea, and vomiting; flu, colds, and viral illnesses; pneumonia and bronchitis; and asthma attacks. The company also offers preventative screenings/wellness services, including flu shots, physicals, immunization and vaccinations, EKGs, and osteoporosis screening, as well as blood glucose, blood pressure, and cholesterol checks; radiology, lab work and diagnostic testing, and drug and alcohol screening services; and services for employers. | $18M | Series D | Oct 12, 2018 | http://www.urgentteam.com |
| Kelly Klee | Kelly Klee is a digital insurance broker providing plans designed to cover important personal assets and wealth. Their service is engineered for busy professionals that wants a modern, technology-enabled solution for their personal insurance. Bob Klee and Jon Kelly established the firm in 2014 in Aspen, Colorado. | $4.5M | Seed | Mar 08, 2018 | https://kellyklee.com/ |
| Lineagen | Lineagen is a provider of diagnostic and healthcare services focused on complex diseases for which an individual's genetic profiles contribute strongly to their susceptibility. Lineagen is committed to improving outcomes for those affected by autism and other complex diseases, for which effective early diagnosis and intervention can have asignificant positive impact. The company's comprehensive genetic testing and support/counseling service are initially designed to enable early evaluation of children at risk for disorders of childhood development, including autism spectrum disorders (ASDs). Founded in 2002, Lineagen's commercial strategy represents the culmination of significant proprietary research into genetic causes and diagnostic pathways of key complex diseases, including autism, MS, and COPD. One of the company's core research competitive advantages is its access through the University of Utah to the Utah Population Database, an unmatched biomarker discovery research platform that has been used to help the University identify more disease-related genes than any other institution in the world. | $12.2M | Series C | Jan 26, 2015 | http://www.lineagen.com |
| Urgent Team Holdings, Inc. | Urgent Team Holdings, Inc. operates urgent care centers that provide urgent and primary health care services. It offers services for patients in the areas of sprains, strains, and broken bones; muscular pain and injuries; eye irritation and eye injuries; cuts and scrapes; bites, stings, and allergic reactions; burns and infections; diarrhea,nausea, and vomiting; flu, colds, and viral illnesses; pneumonia and bronchitis; and asthma attacks. The company also offers preventative screenings/wellness services, including flu shots, physicals, immunization and vaccinations, EKGs, and osteoporosis screening, as well as blood glucose, blood pressure, and cholesterol checks; radiology, lab work and diagnostic testing, and drug and alcohol screening services; and services for employers. | $5.3M | Series B | May 21, 2014 | http://www.urgentteam.com |
| Urgent Team Holdings, Inc. | Urgent Team Holdings, Inc. operates urgent care centers that provide urgent and primary health care services. It offers services for patients in the areas of sprains, strains, and broken bones; muscular pain and injuries; eye irritation and eye injuries; cuts and scrapes; bites, stings, and allergic reactions; burns and infections; diarrhea,nausea, and vomiting; flu, colds, and viral illnesses; pneumonia and bronchitis; and asthma attacks. The company also offers preventative screenings/wellness services, including flu shots, physicals, immunization and vaccinations, EKGs, and osteoporosis screening, as well as blood glucose, blood pressure, and cholesterol checks; radiology, lab work and diagnostic testing, and drug and alcohol screening services; and services for employers. | $35M | Series A | Feb 15, 2012 | http://www.urgentteam.com |
| Access Media 3 | Access Media 3 is led by a team of industry veterans that have identified a clear need for unparalleled service and commitment to the multi-dwelling unit market place (apartments, condominiums, retirement communities & off-campus student housing). | $30M |  | Feb 09, 2012 | http://www.am3inc.com |
| Salveo Specialty Pharmacy | Salveo Specialty Pharmacy® is an independent specialty pharmacy company that provides a wide array of medications and clinical services to patients with chronic conditions."Salveo" means to be well and in good health. Their purpose is to enhance and support the wellness and good health of each and every one of our patients. They workclosely with their customers, referral sources and insurance plans to facilitate the communication needed to achieve a superior level of patient care. |  | Series A | Oct 13, 2011 | http://salveospecialty.com |
| New Century Hospice | Hospice is a program of care and support for a person diagnosed with a terminal illness and comfort care is desired. Helping people find meaning and peace is at the core of our mission.At New Century Hospice, our program supports early involvement where a dramatic difference in the quality of life can be experienced. By enabling families andloved ones to participate in the care experience, we are able to make the remaining time more meaningful, dignified and comfortable. | $20M | Series A | Oct 14, 2010 | http://newcenturyhospice.com |
| New Century Hospice | Hospice is a program of care and support for a person diagnosed with a terminal illness and comfort care is desired. Helping people find meaning and peace is at the core of our mission.At New Century Hospice, our program supports early involvement where a dramatic difference in the quality of life can be experienced. By enabling families andloved ones to participate in the care experience, we are able to make the remaining time more meaningful, dignified and comfortable. | $12M |  | Oct 12, 2010 | http://newcenturyhospice.com |

10 of 12 investments shown.

## Co-investors
- [RC Capital](https://shizune.co/investors/profile/river-cities-capital) — VC Fund, 2 deals together
- [Scale Venture Partners](https://shizune.co/investors/profile/scale-venture-partners) — VC Fund, 2 deals together
- [Archipel Capital](https://shizune.co/investors/profile/archipel-capital) — VC Fund, 1 deal together
- [Canopy Capital Partners](https://shizune.co/investors/profile/canopy-capital-partners-9f0f) — VC Fund, 1 deal together
- [Crestline](https://shizune.co/investors/profile/crestline) — VC Fund, 1 deal together
- [HealthQuest Capital](https://shizune.co/investors/profile/heathquest-capital-2) — VC Fund, 1 deal together

## About Petra Capital Partners

VC Fund · Nashville, United States

Petra Capital Partners is a Nashville, TN based private equity firm founded in 1996, engaged in providing growth capital for companies located throughout the United States. The partners of Petra have invested more than $650 million in 100 high growth private companies over the past 20 years. We are currently investing out of our third fund, closedin May 2013, with $230 million of available capital.We invest up to $20 million of our own capital per company. We are flexible in how we structure each investment to meet the needs of the owners and our own return objectives. We have invested in subordinated debt with warrants and equity securities. In addition to our own capital, Petra's limited partners are capable of providing additional capital in support of our portfolio companies.We are licensed as a Small Business Investment Company (SBIC) by the U.S. Small Business Administration, and was named SBIC of the Year in 2012.

5 contacts available at Petra Capital Partners.

| Name | Title | Profile |
| --- | --- | --- |
| David Fitzgerald | Managing Partner | https://shizune.co/investors/profile/david-fitzgerald |
| Carol Collins | Office Manager | — |
| Charles R. Webb | Associate | — |
| Douglas Owen | Partner | — |
| Matthew S. Sotelo | Associate | — |

## Similar investors

### Similar industry
- [Anthemis](https://shizune.co/investors/profile/anthemis-group) — VC Fund
- [MS&AD Ventures](https://shizune.co/investors/profile/ms-ad-ventures) — VC Fund
- [Everywhere Ventures](https://shizune.co/investors/profile/everywhere-ventures) — VC Fund

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [FJ Labs](https://shizune.co/investors/profile/fj-labs) — VC Fund

### Similar country
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [Right Side Capital Management](https://shizune.co/investors/profile/right-side-capital-management) — VC Fund
- [SV Angel](https://shizune.co/investors/profile/sv-angel) — VC Fund

## Featured in investor lists
- [InsurTech Angel Investors in United States](https://shizune.co/investors/insurtech-angel-investors-united-states)

## FAQ

### What does David Fitzgerald invest in?

David Fitzgerald invests primarily in Health Care, Medical and Hospital startups, most often at Series A and Funding Round stage. Most of the 12 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### How do I contact David Fitzgerald?

Public channels for David Fitzgerald include LinkedIn. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

### When did David Fitzgerald last invest?

The most recent investment recorded for David Fitzgerald closed in Apr 2023. Shizune tracks 12 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co